ASPN, US0453271035

Aspen Aerogels stock edges lower after recent earnings and valuation reset

Published on 09/20/2026 at 12:53 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Aspen Aerogels stock trades near USD 5.07 as of September 19, 2026, after recent quarterly figures and a recalibrated market valuation. The shares reflect the company’s latest revenue and loss trends alongside its current market capitalization.

ASPN, US0453271035, Illustration mit AI erstellt.
ASPN, US0453271035, Illustration mit AI erstellt.

Aspen Aerogels Inc. (ISIN US0453271035) stock is trading around USD 5.07 on Nasdaq as of September 19, 2026, leaving the thermal insulation specialist valued in the low hundreds of millions of dollars and reflecting recent quarterly losses and growth investments. This price level follows the latest reported financial results for 2026 and the market’s reassessment of the company’s prospects and valuation.

Earnings show revenue growth alongside ongoing losses

In its most recent quarterly results for the first half of 2026, Aspen Aerogels reported that revenue continued to grow compared with the prior year period, while the company still posted a net loss as it invests in manufacturing capacity and new customer programs. According to Aspen Aerogels in its latest shareholder update for fiscal 2026, the company’s most recent quarter showed higher product shipments into energy infrastructure and electric vehicle applications, translating into double-digit percent revenue growth versus the same quarter of 2025.

The same filing from Aspen Aerogels indicates that while gross margin improved by several percentage points year on year in the latest quarter of 2026, operating expenses also increased as the company expanded its sales, engineering and production footprint. As a result, the operating loss for the quarter narrowed compared with the equivalent period of 2025 but remained in the tens of millions of dollars, underlining that the business is still in an investment phase rather than at steady-state profitability.

Guidance and market expectations frame the valuation

For the full fiscal year 2026, Aspen Aerogels has issued guidance that foresees continued revenue growth compared with fiscal 2025 and a gradual improvement in margins as new capacity ramps up. According to the latest guidance commentary from Aspen Aerogels, management expects revenue in 2026 to be significantly higher than in 2025, with the percentage increase in the mid-teens, while the adjusted EBITDA loss should narrow by a meaningful margin as volume leverage and cost efficiencies begin to take hold.

Analyst coverage of Aspen Aerogels reflects this mix of growth and losses. Recent commentary from investment research outlets indicates that some analysts still see upside potential in the stock over a multi-year horizon, assuming the company can convert its pipeline in energy infrastructure and electric mobility into sustained cash flow and improve margins. At the same time, a number of analysts emphasize risks related to execution, customer concentration and the need for ongoing capital expenditure, which could weigh on near-term earnings and keep valuation metrics such as price-to-sales and price-to-book elevated versus more mature industrial peers.

Stock price and market metrics as of mid-September 2026

On the market side, Aspen Aerogels stock was quoted at USD 5.07 in recent trading as of September 19, 2026, on its primary listing venue, Nasdaq, representing a daily decline of 1.17% compared with the prior close and reflecting modest volatility around this price level, per data from Pluang’s ASPN overview. At this share price, the company’s market capitalization stands in the lower hundreds of millions of dollars as of September 19, 2026, placing it firmly in the small-cap segment of the US equity market and highlighting the sensitivity of the stock to changes in growth expectations and funding conditions.

Over the last 52 weeks up to mid-September 2026, Aspen Aerogels shares have traded in a range that extends several dollars above and below the current USD 5.07 level, underscoring how investor sentiment has oscillated between optimism on long-term adoption of aerogel-based insulation and caution about ongoing losses and capital needs. For investors, the key question now is whether the company can maintain the revenue growth rates seen in the latest 2026 quarter while further narrowing its operating loss and eventually crossing into positive free cash flow, which would likely be reflected in a higher and more stable stock price.

Aspen Aerogels stock facts

  • Company: Aspen Aerogels Inc.
  • ISIN: US0453271035
  • Ticker: ASPN
  • Trading venue: Nasdaq
  • Price (as of September 19, 2026): 5.07 USD
  • Market capitalization: small-cap range USD (as of September 19, 2026)
  • Sector / Industry: Industrials / Materials, insulation technology
  • Index membership: none of the major large-cap indices

More news and analyses on Aspen Aerogels stock

Disclaimer...

en | US0453271035 | ASPN | boerse | 70136793 | bgmi